Aktis Oncology sets sights on first IPO of 2026

The premier investor event

January 12–14, 2026 | San Francisco, CAJanuary 20–21, 2026 | Digital Partnering

Aktis Oncology sets sights on first IPO of 2026

By Nnenna Ohaka, Reporter, Partnering and InvestmentShare

Related news

The art of capturing better patient data: Designing trials around the lives of patients

LSX World Congress Europe Panel on Oncology’s Next Frontier: Future Opportunities in an Ever-Growing Market

Gilead’s $2.2bn buy of Ouro Medicines includes Galapagos alliance

‘Expect the unexpected’: Navigating biotech M&A in an unpredictable climate